🇺🇸 Polyethylene glycol electrolyte in United States
27 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 27
Most-reported reactions
- Pain — 5 reports (18.52%)
- Pneumonia — 4 reports (14.81%)
- Arthralgia — 3 reports (11.11%)
- Pyrexia — 3 reports (11.11%)
- Acute Kidney Injury — 2 reports (7.41%)
- Acute Respiratory Distress Syndrome — 2 reports (7.41%)
- Alanine Aminotransferase Increased — 2 reports (7.41%)
- Anxiety — 2 reports (7.41%)
- Aspartate Aminotransferase Increased — 2 reports (7.41%)
- Chest Pain — 2 reports (7.41%)
Other Gastroenterology approved in United States
Frequently asked questions
Is Polyethylene glycol electrolyte approved in United States?
Polyethylene glycol electrolyte does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Polyethylene glycol electrolyte in United States?
Ningbo No. 1 Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.